Cell and Gene Therapy Market: Introduction Cell and gene therapy has high potential to eliminate and prevent several chronic disorders as well as life-threatening disorders especially cancer, heart diseases, AIDS, cystic fibrosis, and age-related disorders. The therapy provides complete cure to patients affected with chronic disorders rather than ease of symptoms offered by other treatments. The gene therapy concept emerged in 1989. Since then, researchers have been attempting to leverage the potential of gene therapy for treatment of rare and genetic diseases as well as diseases for which complete cure is not available yet. The first gene therapy product ‘Gendicine’ was developed by Shenzhen SiBiono GeneTech Co. Ltd. in 2003. It was commercialized for the treatment of head and neck cancer in 2004. Since 2004, more than 30,000 patients in China have been treated with Gendicine. Gendicine has exhibited exemplary safety results. When gene therapy is combined with other ...
Today, healthcare organizations operate in a dynamic ecosystem, wherein they are required to adopt unprecedented advancements for diagnostics and therapeutics, every now and then. Healthcare organizations are facing the uphill task to incorporate technological driven processes, and deliver managed care to the discerning consumer.